Navigation Links
Genmab Announces 2008 First Half Year Results
Date:8/27/2008

and development, and on the ofatumumab program, also remain approximately the same as previous guidance.

Conference Call

Genmab will hold a conference call to discuss the 2008 first half year results tomorrow, Thursday, August 28, 2008, at

3.00 pm CEST

2.00 pm BST

9.00 am EDT

The conference call will be held in English.

The dial in numbers are as follows:

+1-877-795-3648 (in the US) and ask for the Genmab conference call

+1-719-325-4750 (outside the US) and ask for the Genmab conference call

A live webcast of the call and relevant slides will be available at http://www.genmab.com. The webcast will also be archived on Genmab's website.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development,
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
2. Genmab Initiates Ofatumumab Phase II Study in Diffuse Large B-Cell Lymphoma
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... 2013 ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale ... announced price reductions on their popular PhenObestin 37.5 non-prescription ... clients to lose weight as effortlessly as possible has ... more than 50%. , Bottles have been reduced from ... all orders will receive free shipping. , Made ...
(Date:5/24/2013)... May 24, 2013 Today, Zane ... Indiana Health Insurance Exchange . Zane Benefits, ... employer sponsored health benefits, is the leader in ... reimbursement arrangements . , According to Zane Benefits’ ... Affordable Care Act (ACA), health insurance coverage for ...
(Date:5/24/2013)... 2013 DePuy ASR lawsuit ... to move forward in courts throughout the country, Bernstein ... California’s San Francisco Superior Court on April 25th, a ... her DePuy hip lawsuit is voluntarily seeking dismissal of ... al., No. CGC11508806; Calif. Super. Ct., San Francisco). , ...
(Date:5/24/2013)... Pomona, Calif. (PRWEB) May 24, 2013 ... has retained its status of “Full Accreditation” for the ... (AVMA) Council on Education (COE). , “This is a ... of our hard work and student outcomes,” said College ... want to express my appreciation to the faculty, staff, ...
(Date:5/24/2013)... 2013 With Memorial Day Weekend upon us, ... is offering tips to help prevent grill fires throughout ... Association (NFPA) reports that gas grills led to an ... or other solid-fueled grills, meanwhile, caused approximately 1,200 home fires ... Amica Insurance is sharing the following tips from the NFPA ...
Breaking Medicine News(10 mins):Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 3Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 4Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2
... June 25 Former U.S. Secretary of State Colin ... than 15,000 Lions volunteers from around the world and call ... these difficult economic times. , , (Logo: ... will deliver the keynote address on the importance and value ...
... 25 Futurist and world-recognized authority on technology trends ... Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) by ... of care, not the price of technology. , ... to an ambulatory surgical center (ASC) has reduced costs ...
... help determine "who owns who" in the world of multi-level marketing. ... suit in state court in Volusia County, Florida, today, "The last ... All we wanted to do was build businesses and help others ... Univera leaders Marshall Douglas and Joe Land, are former distributors of ...
... PF Week Sept. 14 - 21 , , ... (CPF) announced today it has scheduled its 2009 National Pulmonary Fibrosis ... of this year,s activity are to ensure passage of the PFREA, ... in communities nationwide. , , Specifically, the CPF is asking ...
... Late diagnosis costs lives that could be saved with powerful ... Too many Americans with HIV are diagnosed late in the ... benefit of effective treatments, U.S. health officials reported Thursday. , ... but up to a third don,t know they have the ...
... S.D., June 25 The ,Help is Here Express, bus ... of June 29 - July 3 at various cities in ... on programs that provide prescription medicines for free or nearly ... compared to 2.9 percent a year ago, the Partnership for ...
Cached Medicine News:Health News:Colin Powell Applauds Lions for Leadership in Volunteerism as Interest in Volunteer Service Grows 2Health News:Technological Advancements Shift Site-of-Care From the Operating Room to Your Doctor's Office 2Health News:Former Associates File Suit Against Univera: Dietary Supplement Company Accused of Intimidation, Bullying, and Unfair Trade Practices 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 2Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 3Health News:CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week 4Health News:Too Few Americans Get HIV Test Early Enough 2Health News:Too Few Americans Get HIV Test Early Enough 3Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 4
(Date:5/23/2013)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today ... Executive Officer of Neurocrine Biosciences, will be presenting at the ... in Boston.   The live presentation takes place ... 8:20 a.m. Pacific Time.  The presentation will be webcast and ... . If you are unable to attend ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects ... feel younger, and remain socially and professionally engaged, he should ... the overriding message that the Better Hearing Institute ... of National Men,s Health Week , which leads up ... Week runs from June 10 through June 16. ...
(Date:5/23/2013)...  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), ... on intellectual property developed and owned by Hadassah ... medical research center, today announced that its portfolio ... from the Israeli Ministry of Industry and Commerce, ... product development and advance clinical trials. Cell Cure,s ...
Breaking Medicine Technology:Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... include evaluation of safety and tolerability, ... Phase 2 trials -, ROCKVILLE, Md., May 30 ... announced that it has initiated dosing in a Phase,1 ... its lead IAP,inhibitor, HGS1029, as monotherapy in patients with ...
... Correlated With Clinical Response, CHICAGO, May ... today highlighted the potential of its,investigational MAGE-A3 ... studies evaluating highly targeted immunotherapy,as a treatment ... cancer,(NSCLC). These data were presented at the ...
Cached Medicine Technology:Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 2Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 3Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 2New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 3New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 4New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 5New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 6New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma 7
... assay is a direct competitive EIA ... in human serum or plasma. A ... proteins, making it available for antibody ... anti-Testosterone antibody linked to fluorescein isothiocyanate ...
... of circulating testosterone exists as unbound or ... bound to SHBG with high affinity [1], ... albumin. Both the albumin-bound and free fractions ... inhibits testosterone action. Measurement of the free ...
ELISA kit for the quantitative determination of autoantibodies to tissue transglutaminase (tTG) in serum....
... Thyroglobulin (OQTg) Kit is intended for the ... serum as an aid in the detection ... patients who have had thyroid gland ablation ... and who lack serum thyroglobulin antibodies., ,The ...
Medicine Products: